Percutaneous Strategies in Structural Heart Diseases: Focus on Chronic Heart Failure. / Estratégias Percutâneas em Doenças Estruturais: Foco em Insuficiência Cardíaca Crônica.

ABSTRACT

BACKGROUND: Central Illustration Percutaneous Strategies in Structural Heart Diseases Focus on Chronic Heart Failure Transcatheter devices for monitoring and treating advanced chronic heart failure patients. PA pulmonary artery; LA left atrium; AFR atrial flow regulator; TASS Transcatheter Atrial Shunt System; VNS vagus nerve stimulation; BAT baroreceptor activation therapy; RDN renal sympathetic denervation; F approval by the American regulatory agency (FDA); E approval by the European regulatory agency (CE Mark). BACKGROUND: Innovations in devices during the last decade contributed to enhanced diagnosis and treatment of patients with cardiac insufficiency. These tools progressively adapted to minimally invasive strategies with rapid, widespread use. The present article focuses on actual and future directions of device-related diagnosis and treatment of chronic heart failure.